InvestorsHub Logo
Followers 0
Posts 12
Boards Moderated 0
Alias Born 10/05/2017

Re: Riverkid post# 113032

Thursday, 11/09/2017 7:51:19 AM

Thursday, November 09, 2017 7:51:19 AM

Post# of 179937
Ok so this was the article that concerned me, here's the specific excerpt.

"Elizalde fears that a recommendation to regulate CBD will restrict its use to the pharmaceutical industry and deny access to countless patients who already rely on it.

Instead, Elizalde believes that CBD should be classified as a dietary supplement.

“I hope [they] will consider CBD to be similar to vitamin C, a supplement that has a recommended daily dose—not a drug that then needs to be scheduled,” he said.

The decisions of the ECDD could have wide-reaching implications.

A 1971 UN treaty known as the Convention on Psychotropic Substances specifies which substances should be regulated by member nations, including the United States.

A determination by the United Nations that CBD should not be subject to regulation could spur its rescheduling under the Controlled Substances Act. CBD continues to be listed as a Schedule 1 narcotic, despite a 2004 U.S. Ninth Circuit Court of Appeals ruling that non-psychoactive constituents of hemp are not subject to regulation under the law."

So my question is if the UN regulates it as a drug how would the use potentially only be restricted to the pharmaceutical industry and how would that impact Diamond?

https://hightimes.com/news/united-nations-decide-fate-cbd/

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.